XANDU Trademark

Trademark Overview


On Tuesday, January 4, 2011, a trademark application was filed for XANDU with the United States Patent and Trademark Office. The USPTO has given the XANDU trademark a serial number of 85209901. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Wednesday, September 7, 2011. This trademark is owned by Glaxo Group Limited. The XANDU trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
xandu

General Information


Serial Number85209901
Word MarkXANDU
Filing DateTuesday, January 4, 2011
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateWednesday, September 7, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 26, 2011

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateWednesday, September 7, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events


Event DateEvent Description
Wednesday, September 7, 2011ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
Wednesday, September 7, 2011ABANDONMENT - AFTER INTER PARTES DECISION
Wednesday, September 7, 2011OPPOSITION TERMINATED NO. 999999
Wednesday, September 7, 2011OPPOSITION SUSTAINED NO. 999999
Thursday, May 26, 2011OPPOSITION INSTITUTED NO. 999999
Thursday, May 26, 2011OPPOSITION PAPERS RECEIVED AT TTAB
Tuesday, April 26, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 26, 2011PUBLISHED FOR OPPOSITION
Monday, March 21, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 21, 2011ASSIGNED TO EXAMINER
Friday, January 7, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 7, 2011NEW APPLICATION ENTERED IN TRAM